Conversations On Cancer presents “Living with metastatic breast cancer”, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 October 2023, 15:30 (CEST) to 19 October 2023, 17:00 (CEST)
Safety and residue data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6 - Scientific guideline
Guideline on safety and residue data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6
Cookies
Safety and efficacy data requirements for applications for immunological VMPs intended for limited markets but not eligible for authorisation under Art 23 of Reg (EU) 2019-6 - Scientific guideline
User behaviour data: Europa Analytics
Guideline on safety and efficacy data requirements for applications for immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6
Use of clinical study data in medicine evaluation
Proof-of-concept pilot on using data from clinical studies in medicines evaluation: Interim report
Application of EMA’s transparency principles to the clinical study data proof-of-concept pilot